Elixir Capital is a Sydney-based private equity firm investing in the secular trends and supply chains driving technology, healthcare, industrial, and consumer markets in Australia, New Zealand, United Kingdom and Canada.
Our broad members have extensive investment and M&A experience across retail, healthcare, media, consumer goods, financial services and other sectors.
Some of Elixir Capital’s current and former investments include Venzee (Now listed on TSV as VENZ), Liven, Rightangled, Verv, Mute international, Credentially (Formerly known as drfocused) and Yoller (Formerly known as PlanSnap).
Company Details
- Employees
- 2
- Address
- 8/64 Castlereagh St, Sydney,new South Wales 2000,australia
- Industry
- Financial Services
- NAICS
-
Finance and InsuranceMonetary Authorities-Central Bank
- Website
- http://www.elixircapital.co
- Keywords
- Sydney.
- HQ
- Sydney, New South Wales
Elixir Capital Questions
Elixir Capital's website is http://www.elixircapital.co
Elixir Capital's LinkedIn profile is https://au.linkedin.com/company/elixir-capital-australia
Elixir Capital has
2 employees.
View email and phone details for 2
employees at Elixir Capital.
Elixir Capital's industry is
Financial Services
Elixir Capital's top competitors are
Elixir Wealth Advisory For Doctors,
Elixir Equities Pvt. Ltd.,
Elixir Capital Management Limited,
Elixir Capital,
Ellerston Capital,
Next Capital Private Equity,
Laverty Pathology,
Ankor,
Coogee Capital,
First Aid Finance.
Elixir Capital's categories are Financial Services
